Search ( Ctrl + / )
Dr. Reddy's Laboratories Ltd
RDYNYSE
RDYNYSE
RDYNYSE
| Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Statement Date | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
| Cash and Cash Equivalents | 2024 | 2024 | 2024 | 2024 | 2024 | 2024 | 2024 | 2023 |
| Short Term Investments | 46.89B | 51.74B | 89.71B | 74.36B | 65.02B | 54.39B | 53.03B | 60.97B |
| Cash and Short Term Investments | 59.18B | 63.07B | 94.63B | 81.47B | 72.36B | 67.78B | 61.16B | 66.75B |
| Net Receivables | 111.49B | 91.90B | 81.09B | 80.30B | 96.08B | 89.69B | 77.10B | 72.49B |
| Inventory | 71.63B | 72.04B | 68.57B | 63.55B | 60.80B | 56.59B | 52.40B | 48.67B |
| Other Current Assets | 10.71B | 21.11B | 24.91B | 22.73B | 26.71B | 23.45B | 20.51B | 15.12B |
| Total Current Assets | 253.02B | 248.13B | 269.19B | 248.05B | 238.48B | 217.70B | 113.56B | 204.26B |
| Property Plant Equipment Net | 93.05B | 86.69B | 80.34B | 76.89B | 72.80B | 70.48B | 67.21B | 56.54B |
| Goodwill | 11.86B | 11.77B | 4.24B | 4.25B | 4.29B | 4.22B | 4.24B | 5.47B |
| Intangible Assets | 92.93B | 92.12B | 37.13B | 36.95B | 36.91B | 37.06B | 38.07B | 30.72B |
| Goodwill and Intangible Assets | 104.78B | 103.89B | 41.37B | 41.20B | 41.19B | 41.28B | 42.31B | 36.20B |
| Long Term Investments | 9.02B | 5.98B | 5.21B | 5.26B | 8.33B | 5.92B | 4.90B | 6.09B |
| Tax Assets | 18.27B | 17.48B | 14.90B | 10.77B | 10.92B | 10.84B | 9.54B | 7.05B |
| Other Non Current Assets | 2.92B | 3.79B | 4.28B | 5.35B | 1.13B | 812.00M | -14.45B | 12.72B |
| Total Non Current Assets | 228.04B | 217.83B | 146.11B | 139.47B | 134.37B | 129.33B | 109.51B | 118.60B |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 111.97B | 0.00 |
| Total Assets | 481.06B | 465.96B | 415.30B | 387.52B | 372.84B | 347.02B | 335.04B | 322.85B |
| Account Payables | 36.02B | 35.78B | 34.11B | 21.55B | 31.11B | 30.49B | 27.68B | 22.68B |
| Short Term Debt | 43.51B | 41.18B | 24.45B | 14.03B | 13.70B | 7.19B | 7.59B | 12.19B |
| Tax Payables | 3.00B | 5.09B | 4.86B | 2.34B | 4.17B | 3.99B | 4.43B | 2.14B |
| Deferred Revenue | 2.00B | 1.53B | 4.86B | 1.44B | 2.27B | 3.00B | 47.77B | 1.98B |
| Other Current Liabilities | 47.42B | 45.73B | 37.40B | 58.12B | 44.61B | 42.53B | 41.06B | 48.86B |
| Total Current Liabilities | 131.95B | 129.30B | 105.67B | 96.04B | 93.60B | 84.18B | 55.36B | 85.72B |
| Long Term Debt | 7.58B | 7.36B | 6.23B | 5.99B | 6.15B | 6.04B | 4.93B | 1.28B |
| Deferred Revenue Non Current | 905.00M | 999.00M | 2.43B | 1.19B | 1.44B | 1.50B | 60.00M | 1.56B |
| Deferred Tax Liabilities Non Current | 13.90B | 13.83B | 4.79B | 909.00M | 989.00M | 102.00M | 642.00M | 760.00M |
| Other Non Current Liabilities | 5.16B | 5.18B | 3.98B | 4.94B | 5.24B | 3.71B | 4.02B | 676.00M |
| Total Non Current Liabilities | 27.54B | 27.37B | 15.00B | 10.93B | 11.39B | 9.75B | 9.01B | 4.27B |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -9.01B | 0.00 |
| Total Liabilities | 159.49B | 156.67B | 120.67B | 106.97B | 104.99B | 93.94B | 55.36B | 89.99B |
| Common Stock | 834.00M | 834.00M | 834.00M | 834.00M | 834.00M | 834.00M | 833.00M | 833.00M |
| Retained Earnings | 299.35B | 285.18B | 279.26B | 265.26B | 252.08B | 238.23B | 230.02B | 215.59B |
| Accumulated Other Comprehensive Income Loss | 4.48B | 4.52B | 4.68B | 653.00M | 762.00M | 810.00M | 864.00M | 1.27B |
| Other Total Stockholders Equity | 13.05B | 14.81B | 9.85B | 1.71B | 9.71B | 9.60B | 8.63B | 15.17B |
| Total Stockholders Equity | 317.72B | 305.34B | 294.63B | 280.55B | 267.85B | 253.09B | 245.26B | 232.86B |
| Total Liabilities and Stockholders Equity | 481.06B | 465.96B | 415.30B | 387.52B | 372.84B | 347.02B | 335.04B | 322.85B |
| Total Investments | 55.91B | 57.72B | 94.92B | 79.62B | 73.35B | 60.31B | 57.94B | 67.06B |
| Total Debt | 51.09B | 48.54B | 30.68B | 20.02B | 19.85B | 13.23B | 12.52B | 13.47B |
| Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Statement Date | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
| Cash and Cash Equivalents | 2024 | 2024 | 2024 | 2024 | 2024 | 2024 | 2024 | 2023 |
| Short Term Investments | 46.89B | 51.74B | 89.71B | 74.36B | 65.02B | 54.39B | 53.03B | 60.97B |
| Cash and Short Term Investments | 59.18B | 63.07B | 94.63B | 81.47B | 72.36B | 67.78B | 61.16B | 66.75B |
| Net Receivables | 111.49B | 91.90B | 81.09B | 80.30B | 96.08B | 89.69B | 77.10B | 72.49B |
| Inventory | 71.63B | 72.04B | 68.57B | 63.55B | 60.80B | 56.59B | 52.40B | 48.67B |
| Other Current Assets | 10.71B | 21.11B | 24.91B | 22.73B | 26.71B | 23.45B | 20.51B | 15.12B |
| Total Current Assets | 253.02B | 248.13B | 269.19B | 248.05B | 238.48B | 217.70B | 113.56B | 204.26B |
| Property Plant Equipment Net | 93.05B | 86.69B | 80.34B | 76.89B | 72.80B | 70.48B | 67.21B | 56.54B |
| Goodwill | 11.86B | 11.77B | 4.24B | 4.25B | 4.29B | 4.22B | 4.24B | 5.47B |
| Intangible Assets | 92.93B | 92.12B | 37.13B | 36.95B | 36.91B | 37.06B | 38.07B | 30.72B |
| Goodwill and Intangible Assets | 104.78B | 103.89B | 41.37B | 41.20B | 41.19B | 41.28B | 42.31B | 36.20B |
| Long Term Investments | 9.02B | 5.98B | 5.21B | 5.26B | 8.33B | 5.92B | 4.90B | 6.09B |
| Tax Assets | 18.27B | 17.48B | 14.90B | 10.77B | 10.92B | 10.84B | 9.54B | 7.05B |
| Other Non Current Assets | 2.92B | 3.79B | 4.28B | 5.35B | 1.13B | 812.00M | -14.45B | 12.72B |
| Total Non Current Assets | 228.04B | 217.83B | 146.11B | 139.47B | 134.37B | 129.33B | 109.51B | 118.60B |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 111.97B | 0.00 |
| Total Assets | 481.06B | 465.96B | 415.30B | 387.52B | 372.84B | 347.02B | 335.04B | 322.85B |
| Account Payables | 36.02B | 35.78B | 34.11B | 21.55B | 31.11B | 30.49B | 27.68B | 22.68B |
| Short Term Debt | 43.51B | 41.18B | 24.45B | 14.03B | 13.70B | 7.19B | 7.59B | 12.19B |
| Tax Payables | 3.00B | 5.09B | 4.86B | 2.34B | 4.17B | 3.99B | 4.43B | 2.14B |
| Deferred Revenue | 2.00B | 1.53B | 4.86B | 1.44B | 2.27B | 3.00B | 47.77B | 1.98B |
| Other Current Liabilities | 47.42B | 45.73B | 37.40B | 58.12B | 44.61B | 42.53B | 41.06B | 48.86B |
| Total Current Liabilities | 131.95B | 129.30B | 105.67B | 96.04B | 93.60B | 84.18B | 55.36B | 85.72B |
| Long Term Debt | 7.58B | 7.36B | 6.23B | 5.99B | 6.15B | 6.04B | 4.93B | 1.28B |
| Deferred Revenue Non Current | 905.00M | 999.00M | 2.43B | 1.19B | 1.44B | 1.50B | 60.00M | 1.56B |
| Deferred Tax Liabilities Non Current | 13.90B | 13.83B | 4.79B | 909.00M | 989.00M | 102.00M | 642.00M | 760.00M |
| Other Non Current Liabilities | 5.16B | 5.18B | 3.98B | 4.94B | 5.24B | 3.71B | 4.02B | 676.00M |
| Total Non Current Liabilities | 27.54B | 27.37B | 15.00B | 10.93B | 11.39B | 9.75B | 9.01B | 4.27B |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -9.01B | 0.00 |
| Total Liabilities | 159.49B | 156.67B | 120.67B | 106.97B | 104.99B | 93.94B | 55.36B | 89.99B |
| Common Stock | 834.00M | 834.00M | 834.00M | 834.00M | 834.00M | 834.00M | 833.00M | 833.00M |
| Retained Earnings | 299.35B | 285.18B | 279.26B | 265.26B | 252.08B | 238.23B | 230.02B | 215.59B |
| Accumulated Other Comprehensive Income Loss | 4.48B | 4.52B | 4.68B | 653.00M | 762.00M | 810.00M | 864.00M | 1.27B |
| Other Total Stockholders Equity | 13.05B | 14.81B | 9.85B | 1.71B | 9.71B | 9.60B | 8.63B | 15.17B |
| Total Stockholders Equity | 317.72B | 305.34B | 294.63B | 280.55B | 267.85B | 253.09B | 245.26B | 232.86B |
| Total Liabilities and Stockholders Equity | 481.06B | 465.96B | 415.30B | 387.52B | 372.84B | 347.02B | 335.04B | 322.85B |
| Total Investments | 55.91B | 57.72B | 94.92B | 79.62B | 73.35B | 60.31B | 57.94B | 67.06B |
| Total Debt | 51.09B | 48.54B | 30.68B | 20.02B | 19.85B | 13.23B | 12.52B | 13.47B |